Cite
HARVARD Citation
Sabatier, R. et al. (2022). Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular oncology. 16 (10), pp. 2057-2070. [Online].